Eli Lilly Announces a Diabetes Drug Trial for Children

Recently, Eli Lilly announced that it is planning a clinical trial of its diabetes drug Mounjaro in patients who are six years old or older that have obesity. In fact, according to a United States government registry, Eli Lilly is already underway with a Mounjaro trial on children as young as 10 years old who have type 2 diabetes. Meanwhile, the registry also indicates that the company Novo Nordisk, based in Germany, is also performing a late stage trial of the drug semaglutide, which is sold under the brand name Ozempic in kids who are only 6 years old. Ozempic has been reported to do harm, including gastroparesis. If you or your child is injured as a result of Mounjaro/Ozempic, please call the seasoned Chicago-based trial attorneys of Moll Law Group. We represent children nationwide.

Talk to Moll Law Group About Whether Your Claim is Viable

Both Mounjaro and Ozempic have surged in popularity and demand as treatments for diabetes and obesity. Ozempic is a brand name for semaglutide, which is a medication that manages patients’ blood sugar levels by copying the protein glucagon-like peptide 1 (GLP-1). It lowers your hunger cues and slows digestion in the gut, which can result in weight loss.

More than $1.5 billion in sales were generated by Eli Lilly in the first half of 2023, which is a year after it was approved in the United States. However, it is concerning that children will be subjected to clinical trials because there have been reports that these drugs cause harm, and lawsuits filed in connection with that harm. The Mounjaro lawsuits, which are in their infancy at the time, claim that the drug causes severe gastrointestinal trouble including intestinal blockage and gastroparesis and that Eli Lilly did not adequately inform of the risks associated with taking it.

No settlements or jury trials have been scheduled for the Mounjaro lawsuits. Some similar lawsuits are also filed in connection with Ozempic. Symptoms that suggest harm is occurring include gastroparesis and gastrointestinal burning. The FDA has issued a new warning for Ozempic; the new warning specifies that ileus, or intestinal blockage, is associated with use of Ozempic.

If you or your child were injured by a potentially dangerous drug like Mounjaro or Ozempic, you should consider bringing a product liability lawsuit for damages. These lawsuits may be pursued when a drug is defective in terms of its manufacturing, marketing, or design. Marketing defects most often involve the manufacturer’s failure to warn, or failure to adequately warn, about risks associated with taking the drug in question.

The damages we may be able to recover if we can establish liability include medical bills, lost wages, pain and suffering, loss of enjoyment of life, mental anguish, emotional distress, and out-of-pocket costs. Punitive damages may also be warranted if the jury finds that the companies’ behavior was egregious.

Contact Trusted Chicago-based Product Liability Attorneys

It is tremendously hard to watch your child struggle as the result of a pharmaceutical you believed was safe to take. If you or a loved one were harmed by Ozempic, you should call the experienced Chicago-based dangerous drug lawyers of Moll Law Group for a consultation. If we believe you have a viable claim, we can fight for you to receive compensation regardless of where you’re located in the United States. Complete our online form or call us at 312.462.1700.